98 related articles for article (PubMed ID: 11596074)
1. Modulation of expression of the MHC class I-binding natural killer cell receptors, and NK activity in relation to viral load in HIV-infected/AIDS patients.
Ahmad R; Sindhu ST; Tran P; Toma E; Morisset R; Menezes J; Ahmad A
J Med Virol; 2001 Nov; 65(3):431-40. PubMed ID: 11596074
[TBL] [Abstract][Full Text] [Related]
2. 2B4 expression on natural killer cells increases in HIV-1 infected patients followed prospectively during highly active antiretroviral therapy.
Ostrowski SR; Ullum H; Pedersen BK; Gerstoft J; Katzenstein TL
Clin Exp Immunol; 2005 Sep; 141(3):526-33. PubMed ID: 16045743
[TBL] [Abstract][Full Text] [Related]
3. MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction.
Nolting A; Dugast AS; Rihn S; Luteijn R; Carrington MF; Kane K; Jost S; Toth I; Nagami E; Faetkenheuer G; Hartmann P; Altfeld M; Alter G
Virology; 2010 Oct; 406(1):12-20. PubMed ID: 20667578
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C
Lin Z; Kuroki K; Kuse N; Sun X; Akahoshi T; Qi Y; Chikata T; Naruto T; Koyanagi M; Murakoshi H; Gatanaga H; Oka S; Carrington M; Maenaka K; Takiguchi M
Cell Rep; 2016 Nov; 17(9):2210-2220. PubMed ID: 27880898
[TBL] [Abstract][Full Text] [Related]
5. LILRB2 interaction with HLA class I correlates with control of HIV-1 infection.
Bashirova AA; Martin-Gayo E; Jones DC; Qi Y; Apps R; Gao X; Burke PS; Taylor CJ; Rogich J; Wolinsky S; Bream JH; Duggal P; Hussain S; Martinson J; Weintrob A; Kirk GD; Fellay J; Buchbinder SP; Goedert JJ; Deeks SG; Pereyra F; Trowsdale J; Lichterfeld M; Telenti A; Walker BD; Allen RL; Carrington M; Yu XG
PLoS Genet; 2014 Mar; 10(3):e1004196. PubMed ID: 24603468
[TBL] [Abstract][Full Text] [Related]
6. KLRG1 expression on natural killer cells is associated with HIV persistence, and its targeting promotes the reduction of the viral reservoir.
Astorga-Gamaza A; Perea D; Sanchez-Gaona N; Calvet-Mirabent M; Gallego-Cortés A; Grau-Expósito J; Sanchez-Cerrillo I; Rey J; Castellví J; Curran A; Burgos J; Navarro J; Suanzes P; Falcó V; Genescà M; Martín-Gayo E; Buzon MJ
Cell Rep Med; 2023 Oct; 4(10):101202. PubMed ID: 37741278
[TBL] [Abstract][Full Text] [Related]
7. Evasion from NK cell-mediated immune responses by HIV-1.
Jost S; Altfeld M
Microbes Infect; 2012 Sep; 14(11):904-15. PubMed ID: 22626930
[TBL] [Abstract][Full Text] [Related]
8. Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV Infection.
Miller JS; Rhein J; Davis ZB; Cooley S; McKenna D; Anderson J; Escandón K; Wieking G; Reichel J; Thorkelson A; Jorstad S; Safrit JT; Soon-Shiong P; Beilman GJ; Chipman JG; Schacker TW
J Infect Dis; 2024 May; 229(5):1256-1265. PubMed ID: 38207119
[TBL] [Abstract][Full Text] [Related]
9. Mucosal-homing natural killer cells are associated with aging in persons living with HIV.
Kroll KW; Shah SV; Lucar OA; Premeaux TA; Shikuma CM; Corley MJ; Mosher M; Woolley G; Bowler S; Ndhlovu LC; Reeves RK
Cell Rep Med; 2022 Oct; 3(10):100773. PubMed ID: 36208628
[TBL] [Abstract][Full Text] [Related]
10. Persistence of a Skewed Repertoire of NK Cells in People with HIV-1 on Long-Term Antiretroviral Therapy.
Anderko RR; DePuyt AE; Bronson R; Bullotta AC; Aga E; Bosch RJ; Jones RB; Eron JJ; Mellors JW; Gandhi RT; McMahon DK; Macatangay BJ; Rinaldo CR; Mailliard RB
J Immunol; 2024 May; 212(10):1564-1578. PubMed ID: 38551350
[TBL] [Abstract][Full Text] [Related]
11. Mapping the interplay between NK cells and HIV: therapeutic implications.
Anderko RR; Mailliard RB
J Leukoc Biol; 2023 Feb; 113(2):109-138. PubMed ID: 36822173
[TBL] [Abstract][Full Text] [Related]
12. Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C.
Vollmers S; Lobermeyer A; Niehrs A; Fittje P; Indenbirken D; Nakel J; Virdi S; Brias S; Trenkner T; Sauer G; Peine S; Behrens GMN; Lehmann C; Meurer A; Pauli R; Postel N; Roider J; Scholten S; Spinner CD; Stephan C; Wolf E; Wyen C; Richert L; Norman PJ; Sauter J; Schmidt AH; Hoelzemer A; Altfeld M; Körner C
Front Immunol; 2022; 13():922252. PubMed ID: 35911762
[TBL] [Abstract][Full Text] [Related]
13. Targeting NK Cells for HIV-1 Treatment and Reservoir Clearance.
Duan S; Liu S
Front Immunol; 2022; 13():842746. PubMed ID: 35371060
[TBL] [Abstract][Full Text] [Related]
14. Circulating Immune Cell Profile and Changes in Intravenous Immunoglobulin Responsiveness Over the Disease Course in Children With Kawasaki Disease.
Choi IS; Lee MJ; Choi SA; Choi KS; Jeong IS; Cho HJ
Front Pediatr; 2021; 9():792870. PubMed ID: 35186822
[TBL] [Abstract][Full Text] [Related]
15. Changes in NK Cell Subsets and Receptor Expressions in HIV-1 Infected Chronic Patients and HIV Controllers.
Zhang Z; Zhou Y; Lu J; Chen YF; Hu HY; Xu XQ; Fu GF
Front Immunol; 2021; 12():792775. PubMed ID: 34975895
[TBL] [Abstract][Full Text] [Related]
16. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
17. Innate Immune Response Against HIV-1.
Murugaiah V; Yasmin H; Pandit H; Ganguly K; Subedi R; Al-Mozaini M; Madan T; Kishore U
Adv Exp Med Biol; 2021; 1313():23-58. PubMed ID: 34661890
[TBL] [Abstract][Full Text] [Related]
18. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
Front Immunol; 2020; 11():1979. PubMed ID: 32973803
[TBL] [Abstract][Full Text] [Related]
19. Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells.
Porichis F; Hart MG; Massa A; Everett HL; Morou A; Richard J; Brassard N; Veillette M; Hassan M; Ly NL; Routy JP; Freeman GJ; Dubé M; Finzi A; Kaufmann DE
J Immunol; 2018 Aug; 201(3):971-981. PubMed ID: 29934472
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cells in HIV-1 infection and therapy.
Mikulak J; Oriolo F; Zaghi E; Di Vito C; Mavilio D
AIDS; 2017 Nov; 31(17):2317-2330. PubMed ID: 28926399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
